Patent ductus arteriosus and indomethacin treatment as independent risk factors for plus disease in retinopathy of prematurity

Journal of Pediatric Ophthalmology and Strabismus

Volumn 50, Issue 2, 2013, Pages 88-92

  Tsui, Irena ^a   Ebani, Edward ^a   Rosenberg, Jamie B ^a   Lin, Juan ^a   Angert, Robert M ^a   Mian, Umar ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN;

ARTICLE; BIRTH WEIGHT; BLOOD TRANSFUSION; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENDER; GESTATIONAL AGE; HEAD CIRCUMFERENCE; HUMAN; INFANT; LOW LEVEL LASER THERAPY; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEWBORN; NEWBORN INTENSIVE CARE; NEWBORN SCREENING; OUTCOME ASSESSMENT; PATENT DUCTUS ARTERIOSUS; PREMATURITY; RETROLENTAL FIBROPLASIA; RETROSPECTIVE STUDY; SEPSIS;

BIRTH WEIGHT; CROSS-SECTIONAL STUDIES; CYCLOOXYGENASE INHIBITORS; DUCTUS ARTERIOSUS, PATENT; FEMALE; GESTATIONAL AGE; HUMANS; INDOMETHACIN; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; MALE; RETINAL NEOVASCULARIZATION; RETINAL VESSELS; RETINOPATHY OF PREMATURITY; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84877641933     PISSN: 01913913     EISSN: 19382405     Source Type: Journal    
DOI: 10.3928/01913913-20130108-03     Document Type: Article

References (20)

1. Gilbert C. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev. 2008;84:77-82.
2. Tasman W. Retinopathy of prematurity: do we still have a problem? Arch Ophthalmol. 2011;129:1083-1086.
3. Raghuveer TS, Bloom BT. A paradigm shift in the prevention of retinopathy of prematurity. Neonatology. 2011;100:116-129.
4. Kumar P, Sankar MJ, Deorari A, et al. Risk factors for severe retinopathy of prematurity in preterm low birth weight neonates. Indian J Pediatr. 2011;78:812-816.
5. Purohit DM, Ellison RC, Zierler S, Miettinen OS, Nadas AS. Risk factors for retrolental fibroplasia: experience with 3,025 premature infants. National Collaborative Study on Patent Ductus Arteriosus in Premature Infants. Pediatrics. 1985;76:339-344.
6. Bourla DH, Gonzales CR, Valijan S, Yu F, Mango CW, Schwartz SD. Association of systemic risk factors with the progression of laser-treated retinopathy of prematurity to retinal detachment. Retina. 2008;28(3 suppl):S58-S64. Erratum in: Retina. 2009;29:127.
7. Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev. 2003:CD003481.
8. Procianoy RS, Garcia-Prats JA, Hittner HM, Adams JM, Rudolph AJ. Use of indomethacin and its relationship to retinopathy of prematurity in very low birthweight infants. Arch Dis Child. 1980;55:362-364.
9. Jegatheesan P, Ianus V, Buchh B, et al. Increased indomethacin dosing for persistent patent ductus arteriosus in preterm infants: a multicenter, randomized, controlled trial. J Pediatr. 2008;153:183-189.
10. Fielder AR. Preliminary results of treatment of eyes with high-risk prethreshold retinopathy of prematurity in the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003;121:1769-1771.
11. Petersen RA, Rosenthal A. Retinopathy and papilledema in cyanotic congenital heart disease. Pediatrics. 1972;49:243-249.
12. Granstrom KO. Retinal changes in coarctation of the aorta. Br J Ophthalmol. 1951;35:143-148.
13. Ryan RM. A new look at bronchopulmonary dysplasia classification. J Perinatol. 2006;26:207-209.
14. Garcia-Serrano JL, Ramirez-Garcia MC, Pinar-Molina R. Retinopathy of prematurity in multiple births: risk analysis for plus disease [article in Spanish]. Arch Soc Esp Oftalmol. 2009;84:191-198.
15. Tynan M. The ductus arteriosus and its closure. N Engl J Med. 1993;329:1570-1572.
16. Parys-Van Ginderdeuren R, Malcolm D, Varma DR, Aranda JV, Chemtob S. Dissociation between prostaglandin levels and blood flow to the retina and choroid in the newborn pig after nonsteroidal antiinflammatory drugs. Invest Ophthalmol Vis Sci. 1992;33:3378-3384.
17. Beharry KD, Modanlou HD, Hasan J, et al. Comparative effects of early postnatal ibuprofen and indomethacin on VEGF, IGF-I, and GH during rat ocular development. Invest Ophthalmol Vis Sci. 2006;47:3036-3043.
18. Gaugler C, Beladdale J, Astruc D, et al. Retinopathy of prematurity: 10-year retrospective study at the University Hospital of Strasbourg [article in French]. Arch Pediatr. 2002;9:350-357.
19. Fehlmann E, Tapia JL, Fernandez R, et al. Impact of respiratory distress syndrome in very low birth weight infants: a multicenter South-American study [article in Spanish]. Arch Argent Pediatr. 2010;108:393-400.
20. Mansour AM, Bitar FF, Traboulsi EI, et al. Ocular pathology in congenital heart disease. Eye (Lond). 2005;19:29-34.